Compare MESO & NOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MESO | NOG |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | Australia | United States |
| Employees | 81 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.5B |
| IPO Year | N/A | 2000 |
| Metric | MESO | NOG |
|---|---|---|
| Price | $15.63 | $28.57 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 8 |
| Target Price | N/A | ★ $29.43 |
| AVG Volume (30 Days) | 265.6K | ★ 2.1M |
| Earning Date | 01-01-0001 | 05-26-2026 |
| Dividend Yield | N/A | ★ 6.54% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $2,475,723,000.00 |
| Revenue This Year | $644.56 | $8.21 |
| Revenue Next Year | $38.70 | $4.24 |
| P/E Ratio | ★ N/A | $70.69 |
| Revenue Growth | N/A | ★ 11.23 |
| 52 Week Low | $9.61 | $19.88 |
| 52 Week High | $21.50 | $32.62 |
| Indicator | MESO | NOG |
|---|---|---|
| Relative Strength Index (RSI) | 43.52 | 62.51 |
| Support Level | $14.35 | $24.79 |
| Resistance Level | $16.32 | $29.84 |
| Average True Range (ATR) | 0.55 | 1.26 |
| MACD | 0.01 | -0.04 |
| Stochastic Oscillator | 57.09 | 83.98 |
Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).